Results

Total Results: 336 records

Showing results for "breast cancer".

161. Knowledge Brief #1 Public Deliberation on Health Topics (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/deliberative-methods_research.pdf
     February 01, 2013 - Making policy decisions about population screening for breast cancer: The role of citizens’ deliberation

162. Disposition of Comments: Technical Brief No. 39_Disparities and Barriers to Pediatric Cancer Survivorship Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/tech-brief-39-pediatric-cancer-survivorship-comments.pdf
     March 01, 2021 - For example, health plans should cover breast cancer screening - both mammograms and breast MRIs - … Childhood Cancer Survivor Study that evaluated survivorship care service in context of specific outcomes (breast … cancer cardiomyopathy, skin cancer) but are not mentioned (PMID: 21370417, PMID: 25366684.

163. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/disparities-quality-improvement_research-protocol.pdf
     February 23, 2012 - outcomes associated with a targeted set of clinical conditions, namely:  Colorectal cancer  Breast … cancer  Diabetes  Congestive heart failure  Coronary artery disease (including ischemic heart … cancer, colorectal cancer, diabetes, congestive heart failure, hypertension, coronary artery disease … receiving health care in the United States for a priority condition:  Colorectal cancer  Breast … cancer  Diabetes  Congestive heart failure  Coronary artery disease (including ischemic heart

164. Cancer-Drugs-Utilization-Cost Research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-drugs-utilization-cost_research.pdf
     January 01, 2011 - Utilization and cost of anticancer biologic products among Medicare beneficiaries, 2006-2009 Data Points #6Anticancer Biologics From 2006 to 2009, over 800,000 Medicare fee-for-service beneficiaries continuously enrolled in Parts A and B had a claim for an anticancer biologic of interest. Bevacizumab was the m…

165. Research White Paper Managing Missing Data in Patient Registries Addendum Registries for Evaluating Patient Outcomes Third Edition (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/missing-data-registries-guide-3rd-ed-addendum-white-paper.pdf
     February 01, 2018 - death (by any cause besides heart attack) prevents incident heart attack from occurring; in a study of breast … cancer, preventive double mastectomy likewise may be considered a competing risk for breast cancer. … cancer in all individuals – including those who, due to beliefs about their personal risks 3 Managing … Missing Data in Patient Registries of developing breast cancer, undergo a mastectomy preemptively. … In such a setting, the breast cancer status that these women would have had, had they not gotten a mastectomy

166. Module II: Stakeholders and Stakeholder Engagement (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/module-ii-stakeholders-and-stakeholder-engagement.pdf
     June 01, 2011 - o A State Governor o A breast cancer survivor o A retired medical professor o A clinical expert … o A State Governor o A breast cancer survivor o A retired medical professor o A clinical expert … advocacy groups (Consumers United for Evidence-based Healthcare, Research Advocacy Network, National Breast … Cancer ProjectLEAD) § Government agencies that engage patient advocates (FDA patient representative

167. CER 218 Evidence Summary: Long-Term Drug Therapy and Drug Holidays for Osteoporosis Fracture Prevention: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-218-osteoporosis-fracture-prevention-evidence-summary.pdf
     April 01, 2019 - In addition, estrogen/progestin was associated with an increased risk of invasive breast cancer. … cancer with estrogen/progestin compared to placebo may be greater with increased duration of prior … Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results … Breast Cancer Res Treat. 2001 Jan;65(2):125-34. PMID: 11261828. 29. … Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women

168. Disposition of Comments Report for Decision Aids for Cancer Screening and Treatment (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-decision-support-tools_disposition-comments.pdf
     December 23, 2014 - Decision support for patients with early-stage breast cancer: effects of an interactive breast cancer

169. Colorectal-Cancer-Protocol_130520 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/colorectal-cancer-staging_research-protocol.pdf
     May 20, 2013 - estimated to be the cancer site with the second- highest associated cost of care (second only to female breast … cancer).3,4 Although often mentioned together as if they were the same condition, colon and rectal

170. Breastfeeding and Health Outcomes for Infants and Children (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/breastfeeding-health-outcomes-protocol-amendment.pdf
     February 03, 2025 - gestational age infants • Women with medical conditions contraindicated for breastfeeding (e.g., breast … cancer, HIV) Exposures Any exposure to human milk, including feeding at the breast; consuming expressed

171. Colorectal-Cancer-Staging Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-staging_executive.pdf
     September 01, 2014 - Health care costs associated with care of these cancers is high, second only to breast cancer.3,4

172. Breastfeeding and Health Outcomes for Infants and Children (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/breastfeeding-health-outcomes-protocol.pdf
     February 01, 2023 - gestational age infants • Women with medical conditions contraindicated for breastfeeding (e.g., breast … cancer, HIV) Exposures Any exposure to human milk, including feeding at the breast; consuming expressed

173. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/head-neck-cancer_executive.pdf
     May 01, 2010 - Layout 1 Background Head and neck cancers, specifically those arising in the oral cavity, larynx, hypopharynx, oropharynx, nasopharynx, paranasal sinuses/nasal cavity, salivary glands, and occult primaries, account for approximately 3 to 5 percent of cancers in the United States. According to the National Comprehens…

174. Ch 6-User-Guide-To-Ocer 130129 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ch_6-user-guide-to-ocer_130129.pdf
     October 30, 2012 - definitions and objective measures Conceptual Temporal Aspects Objective Measure Incident invasive breast … cancer Incident SEER or state cancer registry data Myocardial infarction Acute, transient (in regard … on mammary tissue and reduce the long-term risk of primary and recurrent invasive and non-invasive breast … cancer.11 Broader or narrower outcome definitions may be appropriate to specific research questions … cancer.

175. Meeting Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/stakeholders-engagement-others_slides-2011.pdf
     January 01, 2011 - Congressionally Directed Medical Research Programs), and disease-specific organizations (e.g., National Breast … Cancer Coalition Project LEAD®, and Ovarian Cancer National Alliance (OCNA)) provide research training … Affiliations Technical Expert Panel (TEP) Members Affiliation Amy Bonoff Patient Advocate, National Breast … Cancer Coalition Project LEAD® Carolyn Branson Consumer Reviewer Administration Manager, SRA International

176. Han (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/han.pdf
     December 26, 2012 -  of examples and representations of different sources of uncertainty in the example of outcomes of breast … cancer treatment • Probability: 20% probability of benefit from treatment (Indeterminacy of  future

177. Strategies To Prevent Weight Gain in Adults: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/weight-gain-future_research.pdf
     January 01, 2020 - Trial http://ClinicalTrials.gov/show/NCT00456131 Ongoing DAMES: Daughters And MothErS Against Breast … Cancer http://ClinicalTrials.gov/show/NCT00630591 Recently Completed Weight Gain Prevention for … Breast Cancer Survivors http://ClinicalTrials.gov/show/NCT00533338 Ongoing Exercise Program of … Breast Cancer Patients Undergoing Chemotherapy With or Without Radiation http://ClinicalTrials.gov … /show/NCT01157767 Ongoing Effects of Physical Activity and Dietary Change in Minority Breast Cancer

178. Cer-242-Radiation-Therapy-Brain-Metastases-Evidence-Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-242-radiation-therapy-brain-metastases-evidence-summary.pdf
     June 01, 2021 - We restricted to studies that included patients with non-small cell lung cancer, breast cancer, and

179. Disposition of Comments for Epoetin and Darbepoetin for Managing Anemia in Patients Undergoing Cancer Treatment (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia-update_disposition-comments.pdf
     April 25, 2013 - Page 56, table 14: Was the data from the PREPARE neoadjuvant breast cancer trial actually included ? … In this reanalysis, the Breast Cancer Erythropoietin Survival Trial (BEST) study had a weight of 20.3% … The 2 breast cancer studies by Möbus et al (n = 643) and Untch et al (n = 729), respectively, both enrolled … Furthermore, these 2 breast cancer studies are an integral part of the pharmacovigilance program because

180. Methods Guide for Medical Test Reviews Chapter 10 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-decision-models_methods.pdf
     July 01, 2012 - For example, the effectiveness of treatment for women with early-stage breast cancer is primarily based … Evaluating new screening tests for breast cancer. BMJ 2006; 332(7543):678-679. 20.